Defusing vaccine skepticism
Public trust is set to explode, taking pandemic progress with it
With vaccine skepticism threatening to shatter pandemic progress, pharma can’t afford to falter
Pharma's warp drive
The key factors helping drugmakers develop a vaccine in record time
Because patients can’t wait
How autologous cell therapy companies can adapt planning processes to maintain operations amid supply chain disruptions.
Under pressure: Can the glass packaging industry withstand the weight of COVID-19?
It was all smiles at the White House in 2017 when executives from Corning Incorporated visited President Trump’s administration to unveil an innovative new pharmaceutical vial...
FDA oks second Pfizer COVID booster
Moderna seeks COVID jab EUA for young kids
Generics manufacturers ink deals to make Pfizer antiviral
Aspen to manufacture J&J COVID vax in South Africa
Moderna sued over COVID vax patent misuse
AstraZeneca nixes beta COVID vax
Steering through turbulence with IoT
How pharma can navigate disruptions by applying Internet of Things technology to supply chains
The COVID-19 vaccine: A developing tale of black and cornered markets
If the data and recipes were compromised by a foreign adversary, that could be used to corner markets on ingredients, components and tools. The result could be price gouging the...
Making hydroxychloroquine great again
How a 65-year old drug became the center of partisan divide
Fighting COVID-19 with AI
Pharma companies are using technology to reinvent the drug discovery process
The higher they fly: Managing pharma’s COVID-19 reputation risk
The response to the COVID-19 crisis is casting a bright reputational halo over the entire industry. But if you’re going to fly close to the sun, you’d better be sure your wings...
Global Dose: Focus on Russia
After building its domestic infrastructure, Russia's pharma industry looks to go global
A new kind of FDA meeting
How COVID-19 is changing the way the FDA approaches interactions with industry
These unprecedented timelines
Pharma’s bumpy race towards a vaccine could offer a fresh start
Coronavirus vaccines: The billion dose dash
Can pharma meet its lofty goals for coronavirus vaccine production?
Taking the lead in pandemic preparedness
Pharma can use its pandemic response momentum to set the pace for a more prepared future
J&J pauses COVID-19 vax production, says report
Medicago, GSK plant-based COVID vax shows high efficacy
J&J seeks FDA EUA for single-shot vax
J&J announces data on single-dose COVID vax
Merck inks $356M deal with U.S. for investigational COVID-19 therapy
Pfizer, Moderna test vaccines against mutated COVID-19
Pfizer vax gets CHMP green light in EU
FDA advisory panel endorses Moderna vax
A historic first: Pfizer vaccine rollout is underway
Sanofi, GSK announced vaccine trial delay
Load More Content